Cell Death–Induced Immunogenicity Enhances Chemoimmunotherapeutic Response by Converting Immune-Excluded Into T-cell Inflamed Bladder Tumors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors
Nat Commun 2022 Mar 28;13(1)1487, F Nikolos, K Hayashi, XP Hoi, ME Alonzo, Q Mo, A Kasabyan, H Furuya, J Trepel, D Di Vizio, J Guarnerio, D Theodorescu, C Rosser, A Apolo, M Galsky, KS ChanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.